Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by deepoil0808on Oct 12, 2021 10:23am
161 Views
Post# 33996985

Revised: 3rd Qtr rev $ 22 million vs 15 million market cap

Revised: 3rd Qtr rev $ 22 million vs 15 million market capLevel 2 is clearing up pretty nicely today, looks like a big chunk of the impatient sellers have sold, so not much overhang.

This is probably one of the last desperate attacks to manipulate the stock prior to a FEROCIOUS RALLY that is going to occur when BLOCKBUSTER RESULTS are going to be released in November 2021.

Projected 3rd quarter revenue:             $ 22 million

Market cap at 4 cents:                             15 million   (391 million shares at .04 cents)

We are now trading at 0.68x 1 time sale.

Pretty impressive. 

TARGET PRICE:    Short term    48 cents           Longer term (1 year)     1.44
<< Previous
Bullboard Posts
Next >>